Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1929 1
1934 1
1935 2
1946 2
1949 2
1950 3
1951 4
1954 2
1955 1
1958 2
1959 2
1960 2
1961 3
1962 2
1963 4
1964 1
1965 5
1966 7
1967 6
1968 6
1969 8
1970 12
1971 6
1972 7
1973 7
1974 2
1975 8
1976 3
1977 4
1978 7
1979 9
1980 3
1981 5
1982 4
1983 4
1984 8
1985 9
1986 4
1987 3
1988 6
1989 11
1990 5
1991 4
1992 3
1993 7
1994 2
1995 13
1996 15
1997 8
1998 11
1999 11
2000 6
2001 3
2002 9
2003 7
2004 8
2005 5
2006 10
2007 10
2008 6
2009 4
2010 5
2011 5
2012 4
2013 10
2014 4
2015 5
2016 7
2017 7
2018 13
2019 9
2020 5
2021 13
2022 7
2023 15
2024 11
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous T-cell lymphoma: diagnosing subtypes and the challenges.
Hague C, Farquharson N, Menasce L, Parry E, Cowan R. Hague C, et al. Among authors: parry e. Br J Hosp Med (Lond). 2022 Apr 2;83(4):1-7. doi: 10.12968/hmed.2021.0149. Epub 2022 Apr 14. Br J Hosp Med (Lond). 2022. PMID: 35506718 Free article. Review.
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Parry EM, Leshchiner I, Guièze R, Johnson C, Tausch E, Parikh SA, Lemvigh C, Broséus J, Hergalant S, Messer C, Utro F, Levovitz C, Rhrissorrakrai K, Li L, Rosebrock D, Yin S, Deng S, Slowik K, Jacobs R, Huang T, Li S, Fell G, Redd R, Lin Z, Knisbacher BA, Livitz D, Schneider C, Ruthen N, Elagina L, Taylor-Weiner A, Persaud B, Martinez A, Fernandes SM, Purroy N, Anandappa AJ, Ma J, Hess J, Rassenti LZ, Kipps TJ, Jain N, Wierda W, Cymbalista F, Feugier P, Kay NE, Livak KJ, Danysh BP, Stewart C, Neuberg D, Davids MS, Brown JR, Parida L, Stilgenbauer S, Getz G, Wu CJ. Parry EM, et al. Nat Med. 2023 Jan;29(1):158-169. doi: 10.1038/s41591-022-02113-6. Epub 2023 Jan 9. Nat Med. 2023. PMID: 36624313 Free PMC article.
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.
Davids MS, Rogers KA, Tyekucheva S, Wang Z, Pazienza S, Renner SK, Montegaard J, Ihuoma U, Lehmberg TZ, Parry EM, Wu CJ, Jacobson CA, Fisher DC, Thompson PA, Brown JR. Davids MS, et al. Among authors: parry em. Blood. 2022 Feb 3;139(5):686-689. doi: 10.1182/blood.2021011386. Blood. 2022. PMID: 34788401 Free PMC article. Clinical Trial.
ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
Parry EM, Lemvigh CK, Deng S, Dangle N, Ruthen N, Knisbacher BA, Broséus J, Hergalant S, Guièze R, Li S, Zhang W, Johnson C, Long JM, Yin S, Werner L, Anandappa A, Purroy N, Gohil S, Oliveira G, Bachireddy P, Shukla SA, Huang T, Khoury JD, Thakral B, Dickinson M, Tam C, Livak KJ, Getz G, Neuberg D, Feugier P, Kharchenko P, Wierda W, Olsen LR, Jain N, Wu CJ. Parry EM, et al. Cancer Cell. 2023 Oct 9;41(10):1803-1816.e8. doi: 10.1016/j.ccell.2023.08.013. Epub 2023 Sep 21. Cancer Cell. 2023. PMID: 37738974 Free PMC article.
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL.
Jain N, Senapati J, Thakral B, Ferrajoli A, Thompson P, Burger J, Basu S, Kadia T, Daver N, Borthakur G, Konopleva M, Pemmaraju N, Parry E, Wu CJ, Khoury J, Bueso-Ramos C, Garg N, Wang X, Lopez W, Ayala A, O'Brien S, Kantarjian H, Keating M, Allison J, Sharma P, Wierda W. Jain N, et al. Among authors: parry e. Blood Adv. 2023 May 23;7(10):1958-1966. doi: 10.1182/bloodadvances.2022008790. Blood Adv. 2023. PMID: 36287248 Free PMC article. Clinical Trial.
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
Kittai AS, Bond D, Huang Y, Bhat SA, Blyth E, Byrd JC, Chavez JC, Davids MS, Dela Cruz JP, Dowling MR, Duffy C, Ho C, Jacobson C, Jaglowski S, Jain N, Lin KH, Miller C, McCarthy C, Omer Z, Parry E, Rai M, Rogers KA, Saha A, Schachter L, Scott H, Senapati J, Shadman M, Siddiqi T, Stephens DM, Vanguru V, Wierda W, Woyach JA, Thompson PA. Kittai AS, et al. Among authors: parry e. J Clin Oncol. 2024 Jun 10;42(17):2071-2079. doi: 10.1200/JCO.24.00033. Epub 2024 Mar 29. J Clin Oncol. 2024. PMID: 38552193
The molecular map of CLL and Richter's syndrome.
Sud A, Parry EM, Wu CJ. Sud A, et al. Among authors: parry em. Semin Hematol. 2024 Apr;61(2):73-82. doi: 10.1053/j.seminhematol.2024.01.009. Epub 2024 Jan 23. Semin Hematol. 2024. PMID: 38368146 Free article. Review.
Changing the narrative on osteoarthritis: A call for global action.
Jinks C, Botto-van Bemden A, Bunzli S, Bowden J, Egerton T, Eyles J, Foster N, Healey EL, Maddison J, O'Brien D, Quicke JG, Schiphof D, Parry E, Thomas MJ, Holden MA; Change OA Narrative (COAN) Initiative. Jinks C, et al. Among authors: parry e. Osteoarthritis Cartilage. 2024 Apr;32(4):414-420. doi: 10.1016/j.joca.2024.02.004. Epub 2024 Feb 12. Osteoarthritis Cartilage. 2024. PMID: 38354847 No abstract available.
437 results